Cosmo Pharmaceuticals NV

COPN

Company Profile

  • Business description

    Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology, and health tech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. The product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10, and CB-01-33.

  • Contact

    Sir John Rogerson’s Quay
    Riverside II
    Dublin2
    IRL

    T: +353 18170370

    E: [email protected]

    https://www.cosmopharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    325

Stocks News & Analysis

stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.
stocks

This might be the best core stock bargain in the US market today

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.
stocks

Data center demand drives strong earnings outlook for SGM

Sims guides huge earnings upgrade as data center metals demand spikes.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,552.2076.600.90%
CAC 407,665.62142.25-1.82%
DAX 4022,380.19459.37-2.01%
Dow JONES (US)45,577.47443.96-0.96%
FTSE 1009,918.33145.17-1.44%
HKSE24,444.50832.82-3.29%
NASDAQ21,647.61443.08-2.01%
Nikkei 22551,582.231,790.30-3.35%
NZX 50 Index12,896.5093.49-0.72%
S&P 5006,506.48100.01-1.51%
S&P/ASX 2008,365.4081.900.99%
SSE Composite Index3,871.1185.95-2.17%

Market Movers